-
Acheson NH, Tamm I (1967) Replication of Semliki Forest Virus: an electron microscopic study. Virol 32:128–143
doi: 10.1016/0042-6822(67)90261-9
-
Anwanwan D, Singh SK, Singh S, Saikam V, Singh R (2020) Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer 1873:188314
doi: 10.1016/j.bbcan.2019.188314
-
Cai J, Lin Y, Zhang H, Liang J, Tan Y, Cavenee WK, Yan G (2017) Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics. Proc Natl Acad Sci USA 114:6812–6817
doi: 10.1073/pnas.1700357114
-
Cossart P, Helenius A (2014) Endocytosis of Viruses and Bacteria. Cold Spring Harb Perspect Biol 6:a016972–a016972
doi: 10.1101/cshperspect.a016972
-
DeTulleo L, Kirchhausen T (1998) The clathrin endocytic pathway in viral infection. EMBO J 17:4585–4593
doi: 10.1093/emboj/17.16.4585
-
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H (2018) The current status and future prospects of oncolytic viruses in clinical trials against melanoma, glioma, pancreatic, and breast cancers. Cancers (Basel) 10:356
doi: 10.3390/cancers10100356
-
Forrester NL, Palacios G, Tesh RB, Savji N, Guzman H, Sherman M, Weaver SC, Lipkin WI (2012) Genome-scale phylogeny of the alphavirus genus suggests a marine origin. J Virol 86:2729–2738
doi: 10.1128/JVI.05591-11
-
Frolova EI, Gorchakov R, Pereboeva L, Atasheva S, Frolov I (2010) Functional sindbis virus replicative complexes are formed at the plasma membrane. J Virol 84:11679–11695
doi: 10.1128/JVI.01441-10
-
Grimley PM, Berezesky IK, Friedman RM (1968) Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol 2:1326–1338
doi: 10.1128/JVI.2.11.1326-1338.1968
-
Hang Z, Wei Y, Zhao X (1996) Electron microscopic observation of hepato cellular carcinoma in 15 cases–an ultrastructural comparison with human embryonic liver. Hua Xi Yi Ke Da Xue Xue Bao 27:332–336 ((in Chinese))
-
Kääriäinen L, Keränen S, Lachmi B, Söderlund H, Tuomi K, Ulmanen I (1975) Replication of Semliki Forest Virus. Med Biol 53:342–351
-
Kallio K, Hellstrom K, Jokitalo E, Ahola T (2016) RNA replication and membrane modification require the same functions of alphavirus nonstructural proteins. J Virol 90:1687–1692
doi: 10.1128/JVI.02484-15
-
Kimanius D, Forsberg BO, Scheres SH, Lindahl E (2016) Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. Elife 5:e18722
doi: 10.7554/eLife.18722
-
Lim EXY, Lee WS, Madzokere ET, Herrero LJ (2018) Mosquitoes as suitable vectors for alphaviruses. Virus 10:84
doi: 10.3390/v10020084
-
Lin Y, Zhang H, Liang J, Li K, Zhu W, Fu L, Wang F, Zheng X, Shi H, Wu S, Xiao X, Chen L, Tang L, Yan M, Yang X, Tan Y, Qiu P, Huang Y, Yin W, Su X, Hu H, Hu J, Yan G (2014) Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. Proc Natl Acad Sci USA 111:E4504–E4512
doi: 10.1073/pnas.1408759111
-
Lundstrom K (2014) Alphavirus-based vaccines. Virus 6:2392–2415
doi: 10.3390/v6062392
-
Lundstrom K (2016) Alphavirus vectors as tools in neuroscience and gene therapy. Virus Res 216:16–25
doi: 10.1016/j.virusres.2015.08.015
-
Lundstrom K (2017) Oncolytic alphaviruses in cancer immunotherapy. Vaccin 5:9
doi: 10.3390/vaccines5020009
-
Markoff L (2015) Chapter 153 - Alphaviruses. In: Bennett JE, Dolin R, Blaser ML (eds) Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 8th edn. Elsevier, Philadelphia, pp 1865-1874.e2
-
Marks M, Marks JL (2016) Viral arthritis. Clin Med 16:129–134
doi: 10.7861/clinmedicine.16-2-129
-
Mendes A, Kuhn RJ (2018) Alphavirus Nucleocapsid Packaging and Assembly. Virus 10:138
doi: 10.3390/v10030138
-
Pol J, Kroemer G, Galluzzi L (2016) First oncolytic virus approved for melanoma immunotherapy. Oncoimmunol 5:e1115641
doi: 10.1080/2162402X.2015.1115641
-
Raja J, Ludwig JM, Gettinger SN, Schalper KA, Kim HS (2018) Oncolytic virus immunotherapy: future prospects for oncology. J Immunother Cancer 6:140
doi: 10.1186/s40425-018-0458-z
-
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RHI, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV (2017) Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy. Cell 170:1109-1119.e10
doi: 10.1016/j.cell.2017.08.027
-
Soonsawad P, Xing L, Milla E, Espinoza JM, Kawano M, Marko M, Hsieh C, Furukawa H, Kawasaki M, Weerachatyanukul W, Srivastava R, Barnett SW, Srivastava IK, Cheng RH (2010) Structural evidence of glycoprotein assembly in cellular membrane compartments prior to alphavirus budding. J Virol 84:11145–11151
doi: 10.1128/JVI.00036-10
-
Spuul P, Balistreri G, Kääriäinen L, Ahola T (2010) Phosphatidylinositol 3-kinase-, actin-, and microtubule-dependent transport of Semliki Forest Virus replication complexes from the plasma membrane to modified lysosomes. J Virol 84:7543–7657
doi: 10.1128/JVI.00477-10
-
Strauss JH, Strauss EG, Kuhn RJ (1995) Budding of alphaviruses. Trends Microbiol 3:346–350
doi: 10.1016/S0966-842X(00)88973-8
-
Tan Y, Lin Y, Li K, Xiao X, Liang J, Cai J, Guo L, Li C, Zhu W, Xing F, Mai J, Gu J, Tan X, Yin W, Lu B, Qiu P, Su X, Gao M, Hu J, He S, Lu L, Gong S, Yan G, Zhang H (2018) Selective antagonism of Bcl-xL potentiates M1 oncolysis by enhancing mitochondrial apoptosis. Hum Gene Ther 29:950–961
doi: 10.1089/hum.2017.055
-
Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ (2007) EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157:38–46
doi: 10.1016/j.jsb.2006.05.009
-
Taylor A, Herrero LJ, Rudd PA, Mahalingam S (2015) Mouse models of alphavirus-induced inflammatory disease. J Gen Virol 96:221–238
doi: 10.1099/vir.0.071282-0
-
Weaver SC, Paessler S (2009) Chapter 21-alphaviral encephalitides. In: Barrett ADT, Stanberry LR (eds) Vaccines for biodefense and emerging and neglected diseases. Academic Press, London, pp 339–359
-
Zhang H, Li K, Lin Y, Xing F, Xiao X, Cai J, Zhu W, Liang J, Tan Y, Fu L, Wang F, Yin W, Lu B, Qiu P, Su X, Gong S, Bai X, Hu J, Yan G (2017) Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma. Sci Transl Med 9:eaaam7996
doi: 10.1126/scitranslmed.aam7996
-
Zhang H, Lin Y, Li K, Liang J, Xiao X, Cai J, Tan Y, Xing F, Mai J, Li Y, Chen W, Sheng L, Gu J, Zhu W, Yin W, Qiu P, Su X, Lu B, Tian X, Liu J, Lu W, Dou Y, Huang Y, Hu B, Kang Z, Gao G, Mao Z, Cheng SY, Lu L, Bai XT, Gong S, Yan G, Hu J (2016) Naturally existing oncolytic virus m1 is nonpathogenic for the nonhuman primates after multiple rounds of repeated intravenous injections. Hum Gene Ther 27:700–711
doi: 10.1089/hum.2016.038
-
Zhang R, Hryc CF, Cong Y, Liu X, Jakana J, Gorchakov R, Baker ML, Weaver SC, Chiu W (2011) 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J 30:3854–3863
doi: 10.1038/emboj.2011.261